Stay updated with breaking news from Darrell Mousseau. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
There's one glaring barrier when it comes to the new Alzheimer's drug that was just given authorization in the U.S.: The cost of the drug named Aduhel...
E-Mail IMAGE: Molecular neurochemist Darrell Mousseau is a professor in USask's Department of Psychiatry and head of the Cell Signalling Laboratory. view more Credit: University of Saskatchewan Findings from a new study on Alzheimer's disease (AD), led by researchers at the University of Saskatchewan (USask), could eventually help clinicians identify people at highest risk for developing the irreversible, progressive brain disorder and pave the way for treatments that slow or prevent its onset. The research, published in the journal Scientific Reports in early January, has demons...